View Author
patient group treatment leukemia study lymphoblastic leukemia expression t-all protocol children lymphoblastic survival vegfc result childhood level vegfr outcome cancer blood factor fication oncology precursor table death b-all analysis precursor b-all relapse classi diagnosis parent dexamethasone signi sample therapy receptor growth maintenance netherland kinase cohort prognostic disease lymphoblastic leukaemia value information number figure subtype response dutch t-cell ptk 787/zk 222584 subgroups tumour preference induction 787/zk amsacrine dcog-all child myeloid leukemia mutation cytogenetic vignette signi ficantly difference event-free abnormality university remission paediatric maintenance treatment astrocytoma bcr –abl mrd levels communication bcr –abl disease
10 Most Recent Publications
|
Different outcome in older children with acute lymphoblastic leukemia with different treatment protocols in the Netherlands
(Article)
Boudestein, K. Kamps, W.A. Veerman, A.J.P. Pieters, R.A. |
2012-01-01
|
|
Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells
(Article)
Sikkema, A.H. Bont, E.S.J.M. de Molema, G. Dimberg, A. Zwiers, P.J. Diks, S.H. Hoving, E.W. Kamps, W.A. Peppelenbosch, M.P. Dunnen, W.F.A. den |
2011-08-01
|
|
Communicating with child patients in pediatric oncology consultations: A vignette study on child patients', parents', and survivors' communication preferences
(Article)
Zwaanswijk, M. Tates, K. Dulmen, S. van Hoogerbrugge, P.M. Kamps, W.A. Beishuizen, A. Bensing, J.M. |
2011-03-01
|
|
High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia
(Article)
Jonge, H.J.M. de Valk, P.J.M. Kamps, W.A. Löwenberg, B. Bont, E.S.J.M. de Veeger, N.J.G.M. Elst, A. ter Boer, M.L. den Cloos, J. Haas, V. de Heuvel-Eibrink, M.M. van den Kaspers, G.J. Zwaan, C.M. |
2010-09-09
|
|
Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004
(Article)
Kamps, W.A. Pal-De Bruin, K.M. van der Veerman, A.J.P. Fiocco, M. Bierings, M. Pieters, R. |
2010-02-01
|
|
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004)
(Article)
Veerman, A.J. Kamps, W.A. Stijnen, Th. Weel Sipman, M.H. van Weerden, J.F. van Wering, E.R. van Does-van der Berg, A. van der Berg, H. van den Berg, E. van den Bökkerink, J.P. Bruin, M.C. Heuvel-Eibrink, M.M. van den Korbijn, C.M. Korthof, E.T. Pal-De Bruin, K.M. van der |
2009-10-01
|
|
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
(Article)
Boer, M.L. den Slegtenhorst, M. van Horstmann, M.A. Janka-Schaub, G.E. Kamps, W.A. Evans, W.E. Pieters, R. Menezes, R.X. de Cheok, M.H. Buijs-Gladdines, J.G.C.A.M. Peters, S.T. Zutven, L.J.C.M. van Beverloo, H.B. Spek, P.J. van der Escherich, G. |
2009-02-01
|
|
CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia
(Article)
Grotel, M. van Heuvel-Eibrink, M.M. van den Wering, E.R. van Noesel, M.M. van Kamps, W.A. Veerman, A.J.P. Pieters, R. Meijerink, J.P.P. |
2008-12-01
|
|
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences
(Article)
Grotel, M. van Meijerink, J.P.P. Veerman, A.J.P. Noesel, M.M. van Pieters, R. Wering, E.R. van Langerak, A.W. Beverloo, H.B. Buijs-Gladdines, J.G.C.A.M. Burger, N.B. Passier, M.M. Lieshout, E.M.M. van Kamps, W.A. |
2008-01-01
|
|
Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death
(Article)
Weidenaar, A.C. Jonge, H.J.M. de Fidler, V. Elst, A. ter Meeuwsen-De Boer, T. Douwes, J. Bouma-Ter Steege, J.C.A. Hählen, K. Kamps, W.A. Bont, E.S.J.M. de |
2008-01-01
|
